208 related articles for article (PubMed ID: 17326091)
1. Gadobenate dimeglumine-enhanced MRI of intraductal papillary mucinous tumor of the bile ducts.
Park MS; Yu JS; Lee DK; Yoon DS; Cha SW; Kim KW
J Magn Reson Imaging; 2007 Mar; 25(3):625-7. PubMed ID: 17326091
[TBL] [Abstract][Full Text] [Related]
2. Double common bile duct: curved-planar reformatted computed tomography (CT) and gadobenate dimeglumine-enhanced MR cholangiography.
Park MS; Kim BC; Kim Ti; Kim MJ; Kim KW
J Magn Reson Imaging; 2008 Jan; 27(1):209-11. PubMed ID: 18157896
[TBL] [Abstract][Full Text] [Related]
3. Visualization of the biliary tract using gadobenate dimeglumine: preliminary findings.
Ergen FB; Akata D; Sarikaya B; Kerimoglu U; Hayran M; Akhan O; Hussain HK
J Comput Assist Tomogr; 2008; 32(1):54-60. PubMed ID: 18303288
[TBL] [Abstract][Full Text] [Related]
4. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis.
Akpinar E; Turkbey B; Karcaaltincaba M; Balli O; Akkapulu N; Balas S; Tirnaksiz B; Akata D; Akhan O
J Magn Reson Imaging; 2009 Sep; 30(3):578-85. PubMed ID: 19711404
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
[TBL] [Abstract][Full Text] [Related]
7. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
8. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
[TBL] [Abstract][Full Text] [Related]
9. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
[TBL] [Abstract][Full Text] [Related]
10. Mucinous cystadenomas and intraductal papillary mucinous tumors of the pancreas in magnetic resonance cholangiopancreatography.
Albert J; Schilling D; Breer H; Jungius KP; Riemann JF; Adamek HE
Endoscopy; 2000 Jun; 32(6):472-6. PubMed ID: 10863915
[TBL] [Abstract][Full Text] [Related]
11. A case of mucin-hypersecreting intrahepatic bile duct tumor associated with pancreatic intraductal papillary mucinous tumor.
Joo YH; Kim MH; Lee SK; Seo DW; Yoo KS; Min YI; Chang JJ; Yu E
Gastrointest Endosc; 2000 Sep; 52(3):409-12. PubMed ID: 10968862
[No Abstract] [Full Text] [Related]
12. Gadoxetic acid disodium-enhanced magnetic resonance imaging for biliary and vascular evaluations in preoperative living liver donors: comparison with gadobenate dimeglumine-enhanced MRI.
Lee MS; Lee JY; Kim SH; Park HS; Kim SH; Lee JM; Han JK; Choi BI
J Magn Reson Imaging; 2011 Jan; 33(1):149-59. PubMed ID: 21182133
[TBL] [Abstract][Full Text] [Related]
13. Direct cholangioscopy using a double-balloon enteroscope: choledochojejunostomy with intraductal biliary carcinoma.
Okabe Y; Kuwaki K; Kawano H; Kaji R; Sugiyama G; Ishida Y; Yasumoto M; Naito Y; Toyonaga A; Tsuruta O; Sata M
Dig Endosc; 2010 Oct; 22(4):319-21. PubMed ID: 21175487
[TBL] [Abstract][Full Text] [Related]
14. Biliary cystic intraductal papillary mucinous tumor and cystadenoma/cystadenocarcinoma: differentiation by CT.
Lim JH; Jang KT; Rhim H; Kim YS; Lee KT; Choi SH
Abdom Imaging; 2007; 32(5):644-51. PubMed ID: 17437076
[TBL] [Abstract][Full Text] [Related]
15. MR imaging findings of early bile duct cancer.
Lee DH; Lee JM; Kim KW; Park HS; Kim SH; Lee JY; Han JK; Choi BI
J Magn Reson Imaging; 2008 Dec; 28(6):1466-75. PubMed ID: 19025934
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-perfusion in intra-axial brain tumors with high relaxivity contrast agents.
Cotton F
Neuroradiology; 2006 Apr; 48 Suppl 1():34-40. PubMed ID: 16699850
[TBL] [Abstract][Full Text] [Related]
17. MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.
Scherr MK; Seitz M; Müller-Lisse UG; Ingrisch M; Reiser MF; Müller-Lisse UL
Eur J Radiol; 2010 Dec; 76(3):359-66. PubMed ID: 20471189
[TBL] [Abstract][Full Text] [Related]
18. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
[TBL] [Abstract][Full Text] [Related]
19. Multinodular focal fatty infiltration of the liver: atypical imaging findings on delayed T1-weighted Gd-BOPTA-enhanced liver-specific MR images.
Marin D; Iannaccone R; Catalano C; Passariello R
J Magn Reson Imaging; 2006 Sep; 24(3):690-4. PubMed ID: 16878304
[TBL] [Abstract][Full Text] [Related]
20. Metastasis versus focal eosinophilic infiltration of the liver in patients with extrahepatic abdominal cancer: an evaluation with gadobenate dimeglumine-enhanced magnetic resonance imaging.
Park MS; Kim MJ; Lim JS; Kim SH; Kim HS; Chung YE; Kim KW
J Comput Assist Tomogr; 2009; 33(1):119-24. PubMed ID: 19188798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
